COUNTRY COMPARISONS · OBSERVED REGISTRY DATA
The same age, sex, and year
Compare source-reported colorectal cancer diagnosis rates in Australia and Canada. These are annual new diagnoses per 100,000 people within the selected age band. The definitions differ: Canada also includes C26.0 and applies its own histology exclusions.
National Canadian figures are unavailable from 2020 because Nova Scotia has not supplied later diagnoses. Selecting “Excluding Nova Scotia” uses that separately published geography throughout the series. Australian observations end in 2021; later projections are excluded.
Comparison year: 2019. Latest year with a reported value for every current selection: 2019.
New diagnoses per 100,000 people in the selected age band
| Country / coverage | Rate per 100,000 |
|---|---|
| Australia | 64.8 |
| Canada (national) | 54.6 |
Missing and suppressed figures are not zero. Lines stop at gaps; no interpolation, extrapolation, or country ranking is applied. Five-year age bands reduce differences in age composition but do not remove differences in definitions, registration, screening, and diagnosis. This is not a measure of care quality or personal risk.
Annual data, source definitions, and reuse
| Year | Australia | Canada (national) |
|---|---|---|
| 2000 | 62.3 | 51.8 |
| 2001 | 55.9 | 54.3 |
| 2002 | 61.0 | 53.9 |
| 2003 | 58.5 | 51.2 |
| 2004 | 59.5 | 51.3 |
| 2005 | 56.9 | 51.7 |
| 2006 | 59.7 | 54.1 |
| 2007 | 60.4 | 54.1 |
| 2008 | 59.8 | 52.0 |
| 2009 | 59.2 | 53.4 |
| 2010 | 60.4 | 53.9 |
| 2011 | 58.2 | 54.2 |
| 2012 | 54.3 | 56.1 |
| 2013 | 52.3 | 52.2 |
| 2014 | 55.9 | 53.1 |
| 2015 | 56.3 | 57.9 |
| 2016 | 55.0 | 56.2 |
| 2017 | 57.0 | 57.3 |
| 2018 | 61.2 | 58.7 |
| 2019 | 64.8 | 54.6 |
Australia: official source. ICD-10 C18–C20; Australian Cancer Database.
Based on Australian Institute of Health and Welfare material. Cancer data in Australia 2025, Book 1a, Table S1a.1. CC BY 4.0.
Canada (national): official source. ICD-O-3 C18.0–C18.9, C19.9, C20.9 and C26.0, with source histology exclusions; Canadian Cancer Registry.
Adapted from Statistics Canada, Table 13-10-0111-01, 2026 release. This does not constitute an endorsement by Statistics Canada. Statistics Canada Open Licence.
The Australian source is Book 1a, Table S1a.1, October 2025. The Canadian table is 13-10-0111-01, released February 2026 with July 2026 corrections. Rates are reproduced at the source's one-decimal precision. Canadian counts are randomly rounded; rates and totals may be revised. Neither source endorses MyRear.
Download the comparison data and provenance (JSON)Compare a matching age band and observation year
The first in-site comparison covers Australia and Canada using their official registry tables. It uses age-specific diagnosis rates per 100,000, rather than combining all-age rates standardised to different populations. The open-ended 90+ group is shown as such.
Why the dates differ
The Australian workbook contains observed records through 2021 and later projections; this chart imports observed records only. The Canadian table provides national figures through 2019. From 2020, national results are unavailable because Nova Scotia has not supplied later diagnoses. Its separately published geography excluding Nova Scotia can be selected for more recent observations; the chart never silently substitutes it for Canada.
Definitions matter
Australia groups ICD-10 C18–C20. Canada's source also includes C26.0, an unspecified intestinal site, and has its own histology rules. Differences in definitions, registry practices and diagnosis can affect comparisons. Source notes and licences are available with the chart. These numbers are not a league table of health systems, an explanation of causes, or a personal risk prediction.
Why the U.S. series is separate
The U.S. SEER charts elsewhere on MyRear have different registry coverage, case definitions, age groupings and reporting periods. We keep those series separate instead of presenting them as harmonised national data.
This is general education for U.S. readers, not a diagnosis or a personal screening plan. Talk with your clinician about your own history and symptoms. Follow your clinic’s instructions.